ArticleBMC cancer2014

Phospho-aspirin (MDC-22) inhibits breast cancer in preclinical animal models: an effect mediated by EGFR inhibition, p53 acetylation and oxidative stress.

Liqun Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.